Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: March 21, 2025
Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D).
Journal: American journal of nephrology
Published: September 07, 2022
Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents-post hoc analyses of the ASCEND-ND and ASCEND-D trials.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: August 12, 2022
The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease.
Journal: Kidney international
Published: July 27, 2022
Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial.
Journal: JAMA internal medicine
Published: April 04, 2022
Safety of daprodustat in patients with anemia of chronic kidney disease: A pooled analysis of phase 3 studies in Japan.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
Published: January 25, 2022
Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority Trial.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: January 14, 2022
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
Journal: The New England journal of medicine
Published: November 05, 2021
Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
Journal: The New England journal of medicine
Published: November 05, 2021
The ASCEND-ND trial: study design and participant characteristics.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: July 23, 2021
Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: December 11, 2020
Last Updated: 09/26/2026